

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.71551523 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.71551523 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.55238829 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.55238829 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.42415591 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25145154 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.16331577 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.16331577 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.16331577 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.73286213 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.67771087 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.50852359 |
| 13 | urea cycle (GO:0000050) | 5.50696226 |
| 14 | urea metabolic process (GO:0019627) | 5.50696226 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.50251237 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43177468 |
| 17 | cellular glucuronidation (GO:0052695) | 5.30488754 |
| 18 | flavonoid metabolic process (GO:0009812) | 5.23446160 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 5.21929953 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.21802010 |
| 21 | drug catabolic process (GO:0042737) | 5.21459702 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 5.20082285 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.07866861 |
| 24 | cysteine metabolic process (GO:0006534) | 5.07641418 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06024217 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.02385360 |
| 27 | phospholipid efflux (GO:0033700) | 5.01044794 |
| 28 | protein carboxylation (GO:0018214) | 4.98526490 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.98526490 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.88733807 |
| 31 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87428485 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.87428485 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.87428485 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.86819503 |
| 35 | bile acid metabolic process (GO:0008206) | 4.83374428 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.79402162 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.78353678 |
| 38 | negative regulation of sterol transport (GO:0032372) | 4.76564178 |
| 39 | negative regulation of cholesterol transport (GO:0032375) | 4.76564178 |
| 40 | uronic acid metabolic process (GO:0006063) | 4.74174862 |
| 41 | glucuronate metabolic process (GO:0019585) | 4.74174862 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.65302259 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.63332529 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 4.63300288 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.62717564 |
| 46 | cholesterol efflux (GO:0033344) | 4.61043356 |
| 47 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.60555954 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.60484830 |
| 49 | plasma lipoprotein particle assembly (GO:0034377) | 4.58360281 |
| 50 | regulation of complement activation (GO:0030449) | 4.55500723 |
| 51 | * response to nitrosative stress (GO:0051409) | 4.54433481 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.52929579 |
| 53 | * xenobiotic catabolic process (GO:0042178) | 4.51349009 |
| 54 | heme transport (GO:0015886) | 4.48709904 |
| 55 | * benzene-containing compound metabolic process (GO:0042537) | 4.44896998 |
| 56 | exogenous drug catabolic process (GO:0042738) | 4.43223386 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.42824345 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.42824345 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.34103813 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.24480273 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.23298643 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 4.22652678 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.17722791 |
| 64 | amine catabolic process (GO:0009310) | 4.17722791 |
| 65 | epoxygenase P450 pathway (GO:0019373) | 4.16830096 |
| 66 | protein-lipid complex assembly (GO:0065005) | 4.14728334 |
| 67 | * glutathione derivative biosynthetic process (GO:1901687) | 4.14693726 |
| 68 | * glutathione derivative metabolic process (GO:1901685) | 4.14693726 |
| 69 | lysine metabolic process (GO:0006553) | 4.06510157 |
| 70 | lysine catabolic process (GO:0006554) | 4.06510157 |
| 71 | intestinal absorption (GO:0050892) | 4.04639495 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.02933713 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.02876941 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.02876941 |
| 75 | cholesterol homeostasis (GO:0042632) | 4.01959136 |
| 76 | glycine metabolic process (GO:0006544) | 4.00539582 |
| 77 | tyrosine metabolic process (GO:0006570) | 4.00258837 |
| 78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96170471 |
| 79 | sterol homeostasis (GO:0055092) | 3.95382153 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.94562910 |
| 81 | glutamate metabolic process (GO:0006536) | 3.89770004 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.89190512 |
| 83 | lipoprotein metabolic process (GO:0042157) | 3.87628305 |
| 84 | serine family amino acid biosynthetic process (GO:0009070) | 3.83960341 |
| 85 | drug metabolic process (GO:0017144) | 3.83605742 |
| 86 | plasma lipoprotein particle organization (GO:0071827) | 3.82949710 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79844516 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.79478384 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.79323950 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.78656745 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.77387889 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.74960516 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.73102895 |
| 94 | fibrinolysis (GO:0042730) | 3.72418159 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.67012895 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.66487733 |
| 97 | arginine metabolic process (GO:0006525) | 3.65751331 |
| 98 | ethanol oxidation (GO:0006069) | 3.63493133 |
| 99 | protein-lipid complex subunit organization (GO:0071825) | 3.62480229 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.62185382 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.58943483 |
| 102 | acute-phase response (GO:0006953) | 3.57424963 |
| 103 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.51882570 |
| 104 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.39890420 |
| 105 | ATP synthesis coupled proton transport (GO:0015986) | 3.39890420 |
| 106 | behavioral response to nicotine (GO:0035095) | 3.33263569 |
| 107 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.19010269 |
| 108 | protein complex biogenesis (GO:0070271) | 3.14429590 |
| 109 | electron transport chain (GO:0022900) | 3.07528347 |
| 110 | respiratory electron transport chain (GO:0022904) | 3.05725814 |
| 111 | prostate gland growth (GO:0060736) | 3.02136296 |
| 112 | positive regulation of meiosis (GO:0045836) | 2.94139201 |
| 113 | gamma-aminobutyric acid transport (GO:0015812) | 2.90056554 |
| 114 | positive regulation of meiotic cell cycle (GO:0051446) | 2.79277365 |
| 115 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.76603602 |
| 116 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73559866 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.68570237 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.68570237 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 2.68570237 |
| 120 | mannosylation (GO:0097502) | 2.60942650 |
| 121 | positive regulation of mitochondrial fission (GO:0090141) | 2.58794774 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56979381 |
| 123 | serotonin metabolic process (GO:0042428) | 2.55718030 |
| 124 | protein localization to cilium (GO:0061512) | 2.50733045 |
| 125 | hydrogen ion transmembrane transport (GO:1902600) | 2.49152366 |
| 126 | protein polyglutamylation (GO:0018095) | 2.48684290 |
| 127 | transmission of nerve impulse (GO:0019226) | 2.45643873 |
| 128 | negative regulation of appetite (GO:0032099) | 2.44581363 |
| 129 | negative regulation of response to food (GO:0032096) | 2.44581363 |
| 130 | regulation of glomerulus development (GO:0090192) | 2.44099915 |
| 131 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.42120416 |
| 132 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.41858685 |
| 133 | regulation of action potential (GO:0098900) | 2.40119821 |
| 134 | primary amino compound metabolic process (GO:1901160) | 2.39580153 |
| 135 | proton transport (GO:0015992) | 2.38459559 |
| 136 | response to pheromone (GO:0019236) | 2.38245714 |
| 137 | hydrogen transport (GO:0006818) | 2.34823386 |
| 138 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.32742976 |
| 139 | startle response (GO:0001964) | 2.30747392 |
| 140 | ketone body metabolic process (GO:1902224) | 2.30343701 |
| 141 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.28163875 |
| 142 | presynaptic membrane assembly (GO:0097105) | 2.28144007 |
| 143 | postsynaptic membrane organization (GO:0001941) | 2.27354734 |
| 144 | regulation of glucokinase activity (GO:0033131) | 2.26115245 |
| 145 | regulation of hexokinase activity (GO:1903299) | 2.26115245 |
| 146 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.25270404 |
| 147 | neuron cell-cell adhesion (GO:0007158) | 2.24070792 |
| 148 | respiratory chain complex IV assembly (GO:0008535) | 2.23818572 |
| 149 | limb bud formation (GO:0060174) | 2.23455811 |
| 150 | peroxisome fission (GO:0016559) | 2.22096638 |
| 151 | platelet dense granule organization (GO:0060155) | 2.20100006 |
| 152 | ATP biosynthetic process (GO:0006754) | 2.19025530 |
| 153 | positive regulation of actin filament depolymerization (GO:0030836) | 2.18918841 |
| 154 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.14893220 |
| 155 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.14838449 |
| 156 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.14258548 |
| 157 | norepinephrine metabolic process (GO:0042415) | 2.13211656 |
| 158 | neuromuscular synaptic transmission (GO:0007274) | 2.13208169 |
| 159 | neuronal action potential propagation (GO:0019227) | 2.13138187 |
| 160 | nonmotile primary cilium assembly (GO:0035058) | 2.13083222 |
| 161 | auditory behavior (GO:0031223) | 2.12164845 |
| 162 | GPI anchor metabolic process (GO:0006505) | 2.12033129 |
| 163 | branched-chain amino acid catabolic process (GO:0009083) | 2.11990017 |
| 164 | calcium ion-dependent exocytosis (GO:0017156) | 2.10680303 |
| 165 | membrane depolarization during action potential (GO:0086010) | 2.10654829 |
| 166 | aggressive behavior (GO:0002118) | 2.09606547 |
| 167 | synapse assembly (GO:0007416) | 2.09085584 |
| 168 | axonal fasciculation (GO:0007413) | 2.08645676 |
| 169 | neuronal action potential (GO:0019228) | 2.07600708 |
| 170 | C4-dicarboxylate transport (GO:0015740) | 2.07112787 |
| 171 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.07019893 |
| 172 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.06794069 |
| 173 | positive regulation of glomerulus development (GO:0090193) | 2.05890719 |
| 174 | presynaptic membrane organization (GO:0097090) | 2.05401966 |
| 175 | nucleobase catabolic process (GO:0046113) | 2.04927378 |
| 176 | artery smooth muscle contraction (GO:0014824) | 2.04666820 |
| 177 | intraciliary transport (GO:0042073) | 2.04359733 |
| 178 | retinal ganglion cell axon guidance (GO:0031290) | 2.04094828 |
| 179 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.03922995 |
| 180 | cellular potassium ion homeostasis (GO:0030007) | 2.02349841 |
| 181 | reflex (GO:0060004) | 2.02168603 |
| 182 | regulation of membrane repolarization (GO:0060306) | 2.02135653 |
| 183 | anterograde axon cargo transport (GO:0008089) | 2.01313113 |
| 184 | cornea development in camera-type eye (GO:0061303) | 2.00198981 |
| 185 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 1.98551737 |
| 186 | cardiac right ventricle morphogenesis (GO:0003215) | 1.98087738 |
| 187 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 1.97990883 |
| 188 | cilium morphogenesis (GO:0060271) | 1.97326738 |
| 189 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 1.96522101 |
| 190 | ATP hydrolysis coupled proton transport (GO:0015991) | 1.96522101 |
| 191 | cytochrome complex assembly (GO:0017004) | 1.96335607 |
| 192 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 1.95886219 |
| 193 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 1.95886219 |
| 194 | indole-containing compound metabolic process (GO:0042430) | 1.95864422 |
| 195 | protein localization to synapse (GO:0035418) | 1.95824836 |
| 196 | C-terminal protein lipidation (GO:0006501) | 1.95654004 |
| 197 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 1.95244175 |
| 198 | epithelial cell maturation (GO:0002070) | 1.95095882 |
| 199 | chaperone-mediated protein transport (GO:0072321) | 1.94870579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.95025074 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.04080963 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.97458430 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.19466685 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.08998171 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83423505 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.75240766 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.60368329 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63880083 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25019853 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.13485937 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.66372476 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62548565 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39479623 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31743305 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25073238 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.21484471 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.11334095 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.10002181 |
| 20 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.09163152 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06767026 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02178265 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01778090 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00390387 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00349237 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5152040 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97613497 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96649099 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89238092 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85871207 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77893841 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77060705 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76323591 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75865946 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75081945 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73682456 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.72705549 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70968459 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69349949 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68570128 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64466810 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63792459 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63076146 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60546874 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58599112 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57900046 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56639400 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.55444098 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52197377 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50561658 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.49506568 |
| 52 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48977616 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48164628 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47299414 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46770006 |
| 56 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46770006 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46346292 |
| 58 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45503813 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45312152 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45042330 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42563938 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42271043 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41990890 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39659316 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.39503810 |
| 66 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39138532 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38117216 |
| 68 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37940583 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36671755 |
| 70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.36434155 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35595823 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.35429583 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34445442 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34398500 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33584402 |
| 76 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32630621 |
| 77 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32196747 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30656037 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30117295 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29980458 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24848489 |
| 82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23085005 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20834077 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20345167 |
| 85 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17367818 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16319376 |
| 87 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16122246 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14326678 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13413237 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13337161 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13030530 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12555170 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11840716 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11565565 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10260930 |
| 96 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09191143 |
| 97 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05283244 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04921611 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04921611 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04791371 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04589008 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04004411 |
| 103 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03853684 |
| 104 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03453434 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02044112 |
| 106 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00933329 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00869865 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00184723 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99805374 |
| 110 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96759890 |
| 111 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96471675 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96253442 |
| 113 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96202791 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95730354 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94690649 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94227684 |
| 117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93759329 |
| 118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93759329 |
| 119 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92953429 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92709348 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92383000 |
| 122 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90233533 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89887562 |
| 124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89125146 |
| 125 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88757780 |
| 126 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88250783 |
| 127 | JUN_21703547_ChIP-Seq_K562_Human | 0.87831925 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86898239 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83435494 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82546922 |
| 131 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81781536 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80672245 |
| 133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80401092 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80335228 |
| 135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79821056 |
| 136 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78815228 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78181162 |
| 138 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75335399 |
| 139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73737943 |
| 140 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73208370 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.72864703 |
| 142 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72629113 |
| 143 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72629113 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70790866 |
| 145 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69336857 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68779917 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67530434 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65327517 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65135405 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65067698 |
| 151 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64561017 |
| 152 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61518355 |
| 153 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60925691 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59885095 |
| 155 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58499782 |
| 156 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55810093 |
| 157 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55395928 |
| 158 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.55201722 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54832702 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53911278 |
| 161 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53674153 |
| 162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52746398 |
| 163 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52282086 |
| 164 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52053415 |
| 165 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50290023 |
| 166 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50129712 |
| 167 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.49894375 |
| 168 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49613523 |
| 169 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49601086 |
| 170 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49479222 |
| 171 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49144326 |
| 172 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48523795 |
| 173 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48503093 |
| 174 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47353413 |
| 175 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46613348 |
| 176 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.46154385 |
| 177 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45860127 |
| 178 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45779053 |
| 179 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.43652434 |
| 180 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.42851030 |
| 181 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42458368 |
| 182 | AR_20517297_ChIP-Seq_VCAP_Human | 0.41149880 |
| 183 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.40592853 |
| 184 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40259121 |
| 185 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40207011 |
| 186 | NCOR_22424771_ChIP-Seq_293T_Human | 0.39436726 |
| 187 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39432827 |
| 188 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39180622 |
| 189 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.38866867 |
| 190 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38846790 |
| 191 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.38829887 |
| 192 | CBP_21632823_ChIP-Seq_H3396_Human | 0.37619643 |
| 193 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.36257485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.44715776 |
| 2 | MP0005360_urolithiasis | 8.17353759 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29275963 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 6.10595322 |
| 5 | MP0005365_abnormal_bile_salt | 6.01957274 |
| 6 | MP0003252_abnormal_bile_duct | 4.08162198 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.89088094 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.48151819 |
| 9 | MP0009840_abnormal_foam_cell | 3.46422506 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.26858866 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.77608048 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.75029133 |
| 13 | MP0005083_abnormal_biliary_tract | 2.57576430 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.43461547 |
| 15 | MP0005332_abnormal_amino_acid | 2.41616975 |
| 16 | MP0003880_abnormal_central_pattern | 2.40237591 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.37374932 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.35270473 |
| 19 | MP0003195_calcinosis | 2.25794311 |
| 20 | MP0002736_abnormal_nociception_after | 2.21494743 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.17586522 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.10819961 |
| 23 | MP0004270_analgesia | 2.04659419 |
| 24 | MP0009046_muscle_twitch | 2.02545841 |
| 25 | MP0000609_abnormal_liver_physiology | 2.02495178 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.97245319 |
| 27 | MP0002102_abnormal_ear_morphology | 1.83473228 |
| 28 | MP0002272_abnormal_nervous_system | 1.81763679 |
| 29 | MP0009745_abnormal_behavioral_response | 1.80302633 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.78308670 |
| 31 | MP0003868_abnormal_feces_composition | 1.76712177 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.74351303 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.69914400 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.68200493 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.65704814 |
| 36 | MP0003122_maternal_imprinting | 1.64614352 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.62376600 |
| 38 | MP0002160_abnormal_reproductive_system | 1.59213926 |
| 39 | MP0009697_abnormal_copulation | 1.57030312 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.56573036 |
| 41 | MP0002064_seizures | 1.55195554 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.54896075 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.50376652 |
| 44 | MP0000427_abnormal_hair_cycle | 1.45442183 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.44749024 |
| 46 | MP0004885_abnormal_endolymph | 1.44261696 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.42793354 |
| 48 | MP0001764_abnormal_homeostasis | 1.42365405 |
| 49 | MP0001486_abnormal_startle_reflex | 1.40491059 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.40019736 |
| 51 | MP0001529_abnormal_vocalization | 1.39580482 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.38743914 |
| 53 | MP0000516_abnormal_urinary_system | 1.38522028 |
| 54 | MP0005367_renal/urinary_system_phenotyp | 1.38522028 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.38469365 |
| 56 | MP0000631_abnormal_neuroendocrine_gland | 1.38190826 |
| 57 | MP0001984_abnormal_olfaction | 1.37115981 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35882848 |
| 59 | MP0001905_abnormal_dopamine_level | 1.35651334 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.28749560 |
| 61 | MP0003283_abnormal_digestive_organ | 1.26555834 |
| 62 | MP0003011_delayed_dark_adaptation | 1.26469993 |
| 63 | MP0005389_reproductive_system_phenotype | 1.25952554 |
| 64 | MP0001970_abnormal_pain_threshold | 1.22726288 |
| 65 | MP0003879_abnormal_hair_cell | 1.22437324 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 1.21023241 |
| 67 | MP0002184_abnormal_innervation | 1.20587897 |
| 68 | MP0004142_abnormal_muscle_tone | 1.20268540 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.19462987 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.13845876 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.13698480 |
| 72 | MP0002063_abnormal_learning/memory/cond | 1.13239227 |
| 73 | MP0005253_abnormal_eye_physiology | 1.13003242 |
| 74 | MP0005187_abnormal_penis_morphology | 1.12324206 |
| 75 | MP0001919_abnormal_reproductive_system | 1.11743343 |
| 76 | MP0002254_reproductive_system_inflammat | 1.10307855 |
| 77 | MP0002938_white_spotting | 1.10155605 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.10147407 |
| 79 | MP0000598_abnormal_liver_morphology | 1.06708022 |
| 80 | MP0001346_abnormal_lacrimal_gland | 1.05613447 |
| 81 | MP0003186_abnormal_redox_activity | 1.02326431 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.01884819 |
| 83 | MP0004215_abnormal_myocardial_fiber | 1.00810061 |
| 84 | MP0000604_amyloidosis | 1.00309628 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.99474794 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.98843778 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.98818982 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.98729825 |
| 89 | MP0000026_abnormal_inner_ear | 0.97865029 |
| 90 | MP0005410_abnormal_fertilization | 0.97144904 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.96921984 |
| 92 | MP0004133_heterotaxia | 0.96435351 |
| 93 | MP0004742_abnormal_vestibular_system | 0.94666129 |
| 94 | MP0000383_abnormal_hair_follicle | 0.94595148 |
| 95 | MP0003938_abnormal_ear_development | 0.93772930 |
| 96 | MP0005645_abnormal_hypothalamus_physiol | 0.93480636 |
| 97 | MP0000778_abnormal_nervous_system | 0.92616859 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.90769812 |
| 99 | MP0009763_increased_sensitivity_to | 0.90350758 |
| 100 | MP0005451_abnormal_body_composition | 0.89059097 |
| 101 | MP0009764_decreased_sensitivity_to | 0.88225501 |
| 102 | MP0004085_abnormal_heartbeat | 0.87814141 |
| 103 | MP0005386_behavior/neurological_phenoty | 0.87746539 |
| 104 | MP0004924_abnormal_behavior | 0.87746539 |
| 105 | MP0005503_abnormal_tendon_morphology | 0.87356323 |
| 106 | MP0002822_catalepsy | 0.87133347 |
| 107 | MP0002090_abnormal_vision | 0.86897882 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.85993351 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.85849369 |
| 110 | MP0003942_abnormal_urinary_system | 0.84836436 |
| 111 | MP0008469_abnormal_protein_level | 0.83625510 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.83126045 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.82856303 |
| 114 | MP0000049_abnormal_middle_ear | 0.81929075 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.80904842 |
| 116 | MP0001501_abnormal_sleep_pattern | 0.80791754 |
| 117 | MP0005408_hypopigmentation | 0.80591485 |
| 118 | MP0002282_abnormal_trachea_morphology | 0.80178017 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.80175399 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.79183232 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.79123556 |
| 122 | MP0009053_abnormal_anal_canal | 0.79090889 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.78976110 |
| 124 | MP0005647_abnormal_sex_gland | 0.78838200 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.78580395 |
| 126 | MP0002928_abnormal_bile_duct | 0.77110497 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.76859950 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.75870637 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.74798335 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.74387006 |
| 131 | MP0008872_abnormal_physiological_respon | 0.69471146 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.68340146 |
| 133 | MP0005266_abnormal_metabolism | 0.67659566 |
| 134 | MP0003329_amyloid_beta_deposits | 0.67385114 |
| 135 | MP0002876_abnormal_thyroid_physiology | 0.66673660 |
| 136 | MP0003718_maternal_effect | 0.65596268 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.65342618 |
| 138 | MP0005448_abnormal_energy_balance | 0.63837414 |
| 139 | MP0003690_abnormal_glial_cell | 0.61957621 |
| 140 | MP0002971_abnormal_brown_adipose | 0.61271532 |
| 141 | MP0005334_abnormal_fat_pad | 0.57964732 |
| 142 | MP0008873_increased_physiological_sensi | 0.57547964 |
| 143 | MP0010368_abnormal_lymphatic_system | 0.57489102 |
| 144 | MP0002796_impaired_skin_barrier | 0.56231772 |
| 145 | MP0005220_abnormal_exocrine_pancreas | 0.49925585 |
| 146 | MP0005535_abnormal_body_temperature | 0.49440558 |
| 147 | MP0000462_abnormal_digestive_system | 0.49422978 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.49305308 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.48959627 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.48885593 |
| 151 | MP0001756_abnormal_urination | 0.47422868 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.46347073 |
| 153 | MP0001661_extended_life_span | 0.45395132 |
| 154 | MP0006035_abnormal_mitochondrial_morpho | 0.45043395 |
| 155 | MP0005395_other_phenotype | 0.44880477 |
| 156 | MP0004043_abnormal_pH_regulation | 0.43512685 |
| 157 | MP0008874_decreased_physiological_sensi | 0.42076519 |
| 158 | MP0005166_decreased_susceptibility_to | 0.40637744 |
| 159 | MP0004782_abnormal_surfactant_physiolog | 0.39856523 |
| 160 | MP0005670_abnormal_white_adipose | 0.39839663 |
| 161 | MP0009384_cardiac_valve_regurgitation | 0.39584069 |
| 162 | MP0001663_abnormal_digestive_system | 0.38831810 |
| 163 | MP0005248_abnormal_Harderian_gland | 0.38318516 |
| 164 | MP0001881_abnormal_mammary_gland | 0.37106033 |
| 165 | MP0003953_abnormal_hormone_level | 0.37090393 |
| 166 | MP0005381_digestive/alimentary_phenotyp | 0.36990915 |
| 167 | MP0003436_decreased_susceptibility_to | 0.36970979 |
| 168 | MP0003075_altered_response_to | 0.36397104 |
| 169 | MP0003724_increased_susceptibility_to | 0.35237297 |
| 170 | MP0004130_abnormal_muscle_cell | 0.34223177 |
| 171 | MP0000579_abnormal_nail_morphology | 0.34112347 |
| 172 | MP0005167_abnormal_blood-brain_barrier | 0.32286189 |
| 173 | MP0003300_gastrointestinal_ulcer | 0.30915637 |
| 174 | MP0004147_increased_porphyrin_level | 0.30865416 |
| 175 | MP0009379_abnormal_foot_pigmentation | 0.30380840 |
| 176 | MP0000249_abnormal_blood_vessel | 0.30362386 |
| 177 | MP0009115_abnormal_fat_cell | 0.30322783 |
| 178 | MP0004883_abnormal_blood_vessel | 0.30258537 |
| 179 | MP0003453_abnormal_keratinocyte_physiol | 0.28873682 |
| 180 | MP0000538_abnormal_urinary_bladder | 0.28391982 |
| 181 | MP0001845_abnormal_inflammatory_respons | 0.27922210 |
| 182 | MP0004947_skin_inflammation | 0.25140510 |
| 183 | MP0010155_abnormal_intestine_physiology | 0.25110040 |
| 184 | MP0000477_abnormal_intestine_morphology | 0.24752032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.38040334 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 7.37587856 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.91936668 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.80927745 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.75860308 |
| 6 | Xanthomatosis (HP:0000991) | 6.16911757 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.93456547 |
| 8 | Hypolipoproteinemia (HP:0010981) | 5.06840481 |
| 9 | Fat malabsorption (HP:0002630) | 4.96846919 |
| 10 | Complement deficiency (HP:0004431) | 4.96662623 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.93418083 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.89616716 |
| 13 | Epidermoid cyst (HP:0200040) | 4.66535021 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.55980888 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.54502742 |
| 16 | Joint hemorrhage (HP:0005261) | 4.38548611 |
| 17 | Hyperammonemia (HP:0001987) | 4.34596728 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29227537 |
| 19 | Hyperglycinemia (HP:0002154) | 4.02345200 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95365840 |
| 21 | Hyperglycinuria (HP:0003108) | 3.93112595 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.90490029 |
| 23 | Hypercholesterolemia (HP:0003124) | 3.87511161 |
| 24 | Hyperbilirubinemia (HP:0002904) | 3.82492639 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.79396196 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.78591006 |
| 27 | Ketosis (HP:0001946) | 3.73267315 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.71859610 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71859610 |
| 30 | Acanthocytosis (HP:0001927) | 3.68998262 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.65591844 |
| 32 | Abnormality of complement system (HP:0005339) | 3.64673655 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 3.54990649 |
| 34 | Steatorrhea (HP:0002570) | 3.52937143 |
| 35 | Concave nail (HP:0001598) | 3.50562277 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40919217 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.37889050 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.35986787 |
| 39 | Progressive macrocephaly (HP:0004481) | 3.28373545 |
| 40 | Mitochondrial inheritance (HP:0001427) | 3.16901003 |
| 41 | Malnutrition (HP:0004395) | 3.16612382 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10394359 |
| 43 | Acute encephalopathy (HP:0006846) | 3.06035714 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05364165 |
| 45 | Pancreatic cysts (HP:0001737) | 3.03785514 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01890852 |
| 47 | Skin nodule (HP:0200036) | 2.93777561 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.92960715 |
| 49 | Cholecystitis (HP:0001082) | 2.92960715 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.89101723 |
| 51 | Ketoacidosis (HP:0001993) | 2.86598708 |
| 52 | Increased CSF lactate (HP:0002490) | 2.81658983 |
| 53 | True hermaphroditism (HP:0010459) | 2.76432708 |
| 54 | Hepatic necrosis (HP:0002605) | 2.73231650 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.72911694 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.71728298 |
| 57 | Spontaneous abortion (HP:0005268) | 2.71218883 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.67461369 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.67172902 |
| 60 | Metabolic acidosis (HP:0001942) | 2.65948841 |
| 61 | Myocardial infarction (HP:0001658) | 2.65551762 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.60466916 |
| 63 | Cholelithiasis (HP:0001081) | 2.59725179 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.59121705 |
| 65 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58579560 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.58471195 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.54885387 |
| 68 | Type II lissencephaly (HP:0007260) | 2.53797195 |
| 69 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52072837 |
| 70 | Molar tooth sign on MRI (HP:0002419) | 2.51218922 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.51218922 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.50802760 |
| 73 | Delayed CNS myelination (HP:0002188) | 2.49386559 |
| 74 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47226565 |
| 75 | Methylmalonic acidemia (HP:0002912) | 2.45860655 |
| 76 | Lethargy (HP:0001254) | 2.44895800 |
| 77 | Poikilocytosis (HP:0004447) | 2.41770423 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.41526516 |
| 79 | Late onset (HP:0003584) | 2.40269221 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 2.37462389 |
| 81 | Glomerulonephritis (HP:0000099) | 2.37105129 |
| 82 | Vascular calcification (HP:0004934) | 2.36974305 |
| 83 | Nephronophthisis (HP:0000090) | 2.34824264 |
| 84 | Myokymia (HP:0002411) | 2.32046476 |
| 85 | Focal motor seizures (HP:0011153) | 2.31260294 |
| 86 | Irritability (HP:0000737) | 2.30633519 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29254121 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.29254121 |
| 89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.29036141 |
| 90 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.29036141 |
| 91 | Amyloidosis (HP:0011034) | 2.28652339 |
| 92 | Hemiparesis (HP:0001269) | 2.28392720 |
| 93 | Esophageal varix (HP:0002040) | 2.26817773 |
| 94 | Gait imbalance (HP:0002141) | 2.26547219 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24314215 |
| 96 | Hyperventilation (HP:0002883) | 2.23993729 |
| 97 | Increased circulating renin level (HP:0000848) | 2.23276419 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.22328150 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.22093863 |
| 100 | Hydroxyprolinuria (HP:0003080) | 2.21062024 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.21062024 |
| 102 | Gout (HP:0001997) | 2.20955674 |
| 103 | Spastic diplegia (HP:0001264) | 2.19435324 |
| 104 | Polydipsia (HP:0001959) | 2.18663662 |
| 105 | Abnormal drinking behavior (HP:0030082) | 2.18663662 |
| 106 | Large for gestational age (HP:0001520) | 2.18363363 |
| 107 | Mitral stenosis (HP:0001718) | 2.16877603 |
| 108 | Rickets (HP:0002748) | 2.15804852 |
| 109 | Neonatal onset (HP:0003623) | 2.15778247 |
| 110 | Renal cortical cysts (HP:0000803) | 2.14674579 |
| 111 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14434674 |
| 112 | Cerebral edema (HP:0002181) | 2.13668148 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 2.13558328 |
| 114 | Short tibia (HP:0005736) | 2.11826340 |
| 115 | Cardiovascular calcification (HP:0011915) | 2.10209640 |
| 116 | Abnormality of the renal medulla (HP:0100957) | 2.09789233 |
| 117 | Ileus (HP:0002595) | 2.09773224 |
| 118 | Hypothermia (HP:0002045) | 2.09562394 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 2.09559965 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.08438137 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08316891 |
| 122 | Menorrhagia (HP:0000132) | 2.08308645 |
| 123 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.08203159 |
| 124 | Glycosuria (HP:0003076) | 2.07788927 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 2.07788927 |
| 126 | Male pseudohermaphroditism (HP:0000037) | 2.07741465 |
| 127 | Gingival bleeding (HP:0000225) | 2.07664873 |
| 128 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.06208251 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 2.05775191 |
| 130 | Cystic liver disease (HP:0006706) | 2.05697839 |
| 131 | Progressive cerebellar ataxia (HP:0002073) | 2.05636376 |
| 132 | Congenital primary aphakia (HP:0007707) | 2.04705126 |
| 133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.04130128 |
| 134 | Reticulocytosis (HP:0001923) | 2.02363836 |
| 135 | Focal seizures (HP:0007359) | 2.01359262 |
| 136 | Pancreatitis (HP:0001733) | 2.00627090 |
| 137 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96974844 |
| 138 | Symptomatic seizures (HP:0011145) | 1.95183122 |
| 139 | Increased corneal curvature (HP:0100692) | 1.94588683 |
| 140 | Keratoconus (HP:0000563) | 1.94588683 |
| 141 | Vomiting (HP:0002013) | 1.92014782 |
| 142 | Nephritis (HP:0000123) | 1.91922132 |
| 143 | Hypomagnesemia (HP:0002917) | 1.91048746 |
| 144 | Cerebellar dysplasia (HP:0007033) | 1.90960443 |
| 145 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89373813 |
| 146 | Opisthotonus (HP:0002179) | 1.88449841 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.87969282 |
| 148 | Polyuria (HP:0000103) | 1.87322339 |
| 149 | Brushfield spots (HP:0001088) | 1.86117453 |
| 150 | Hyperglycemia (HP:0003074) | 1.86095074 |
| 151 | Abnormality of renal resorption (HP:0011038) | 1.86014670 |
| 152 | Right ventricular cardiomyopathy (HP:0011663) | 1.85737173 |
| 153 | Hyperuricemia (HP:0002149) | 1.85193599 |
| 154 | Increased purine levels (HP:0004368) | 1.85193599 |
| 155 | Hemorrhage of the eye (HP:0011885) | 1.84734924 |
| 156 | Hyperalaninemia (HP:0003348) | 1.84586923 |
| 157 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84586923 |
| 158 | Abnormality of alanine metabolism (HP:0010916) | 1.84586923 |
| 159 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84208886 |
| 160 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83132204 |
| 161 | Respiratory failure (HP:0002878) | 1.82819343 |
| 162 | Methylmalonic aciduria (HP:0012120) | 1.82798341 |
| 163 | Limb dystonia (HP:0002451) | 1.82083244 |
| 164 | Genital tract atresia (HP:0001827) | 1.80902538 |
| 165 | Sclerocornea (HP:0000647) | 1.80323332 |
| 166 | Poor suck (HP:0002033) | 1.79095784 |
| 167 | Congenital stationary night blindness (HP:0007642) | 1.78993240 |
| 168 | Generalized aminoaciduria (HP:0002909) | 1.78729208 |
| 169 | Vaginal atresia (HP:0000148) | 1.76804212 |
| 170 | Metabolic alkalosis (HP:0200114) | 1.75623106 |
| 171 | Retinal dysplasia (HP:0007973) | 1.75300875 |
| 172 | Tubular atrophy (HP:0000092) | 1.73935573 |
| 173 | Agitation (HP:0000713) | 1.72690571 |
| 174 | Lactic acidosis (HP:0003128) | 1.72573578 |
| 175 | Furrowed tongue (HP:0000221) | 1.71820805 |
| 176 | Febrile seizures (HP:0002373) | 1.71780002 |
| 177 | Gaze-evoked nystagmus (HP:0000640) | 1.70365303 |
| 178 | Epileptiform EEG discharges (HP:0011182) | 1.69631262 |
| 179 | Oligomenorrhea (HP:0000876) | 1.68647235 |
| 180 | Optic disc pallor (HP:0000543) | 1.67858357 |
| 181 | Increased serum lactate (HP:0002151) | 1.67556368 |
| 182 | Increased muscle lipid content (HP:0009058) | 1.67039497 |
| 183 | Atonic seizures (HP:0010819) | 1.66428364 |
| 184 | Severe muscular hypotonia (HP:0006829) | 1.65618776 |
| 185 | Proximal tubulopathy (HP:0000114) | 1.65414141 |
| 186 | Occipital encephalocele (HP:0002085) | 1.64121700 |
| 187 | Goiter (HP:0000853) | 1.64106433 |
| 188 | Amblyopia (HP:0000646) | 1.63844496 |
| 189 | EEG with generalized epileptiform discharges (HP:0011198) | 1.63260500 |
| 190 | Akinesia (HP:0002304) | 1.62212662 |
| 191 | Pendular nystagmus (HP:0012043) | 1.62090317 |
| 192 | Syncope (HP:0001279) | 1.60098449 |
| 193 | Lissencephaly (HP:0001339) | 1.59498940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.52428379 |
| 2 | ERN1 | 4.71478523 |
| 3 | TAOK3 | 3.91520416 |
| 4 | MST1R | 3.78948033 |
| 5 | FGFR4 | 3.75845243 |
| 6 | SIK1 | 3.51761567 |
| 7 | FRK | 3.27225402 |
| 8 | WNK3 | 3.12257800 |
| 9 | PINK1 | 2.98878773 |
| 10 | ERBB4 | 2.81603872 |
| 11 | MAP3K12 | 2.74832403 |
| 12 | CASK | 2.73683565 |
| 13 | MARK1 | 2.36147282 |
| 14 | LIMK1 | 2.35791849 |
| 15 | INSRR | 2.32458331 |
| 16 | GRK6 | 2.29332598 |
| 17 | MAP4K2 | 1.98869373 |
| 18 | TESK1 | 1.97715468 |
| 19 | PTK6 | 1.93392206 |
| 20 | DAPK2 | 1.92374051 |
| 21 | PHKG1 | 1.87132997 |
| 22 | PHKG2 | 1.87132997 |
| 23 | MAP2K4 | 1.85347865 |
| 24 | MAPK13 | 1.79765033 |
| 25 | PNCK | 1.75005885 |
| 26 | MAPK11 | 1.72534178 |
| 27 | RIPK1 | 1.66271556 |
| 28 | PKN2 | 1.62147354 |
| 29 | ADRBK2 | 1.61642065 |
| 30 | BMPR1B | 1.60758883 |
| 31 | MAPKAPK3 | 1.58942176 |
| 32 | WEE1 | 1.58568940 |
| 33 | MUSK | 1.58222837 |
| 34 | MAP3K10 | 1.56797038 |
| 35 | VRK2 | 1.56001367 |
| 36 | BRSK2 | 1.55177730 |
| 37 | MET | 1.54125086 |
| 38 | LATS1 | 1.53859774 |
| 39 | OXSR1 | 1.52403227 |
| 40 | TYK2 | 1.47408938 |
| 41 | STK39 | 1.46006144 |
| 42 | MAP3K7 | 1.35714804 |
| 43 | NUAK1 | 1.33222399 |
| 44 | LMTK2 | 1.32930677 |
| 45 | TRIB3 | 1.32599091 |
| 46 | CSNK1G3 | 1.32426104 |
| 47 | DYRK2 | 1.31006202 |
| 48 | CSNK1G2 | 1.30599739 |
| 49 | ERBB2 | 1.30473705 |
| 50 | PLK2 | 1.29963465 |
| 51 | PIK3CG | 1.28888586 |
| 52 | EPHB1 | 1.26977201 |
| 53 | ABL2 | 1.25576986 |
| 54 | TLK1 | 1.25378895 |
| 55 | MAPKAPK5 | 1.23190898 |
| 56 | MAP3K11 | 1.20710253 |
| 57 | MAP2K7 | 1.19767854 |
| 58 | ZAK | 1.19312364 |
| 59 | GRK5 | 1.19073741 |
| 60 | CSNK1A1L | 1.17857084 |
| 61 | MAP3K2 | 1.17277839 |
| 62 | FLT3 | 1.15772720 |
| 63 | PRKG2 | 1.15517478 |
| 64 | NTRK3 | 1.11225545 |
| 65 | PRKCE | 1.10655081 |
| 66 | PRKAA2 | 1.10594924 |
| 67 | NEK9 | 1.08460358 |
| 68 | MAP2K2 | 1.07814143 |
| 69 | EIF2AK1 | 1.04189252 |
| 70 | JAK2 | 1.03199223 |
| 71 | CAMK2B | 1.00296405 |
| 72 | MAP2K6 | 0.99962655 |
| 73 | MINK1 | 0.98425464 |
| 74 | BRSK1 | 0.97830957 |
| 75 | PIK3CA | 0.97467490 |
| 76 | TBK1 | 0.95733346 |
| 77 | WNK4 | 0.95497610 |
| 78 | KSR2 | 0.94693211 |
| 79 | MAP3K14 | 0.93066419 |
| 80 | PTK2 | 0.90278933 |
| 81 | TRIM28 | 0.90249630 |
| 82 | KDR | 0.90186462 |
| 83 | OBSCN | 0.89014770 |
| 84 | JAK1 | 0.87772855 |
| 85 | STK16 | 0.86013428 |
| 86 | MAPK4 | 0.85889486 |
| 87 | PRKACG | 0.85465697 |
| 88 | MAP2K1 | 0.85458744 |
| 89 | CAMK2A | 0.84676521 |
| 90 | NTRK2 | 0.84515879 |
| 91 | TNIK | 0.84471495 |
| 92 | VRK1 | 0.82988249 |
| 93 | PBK | 0.81332562 |
| 94 | CAMK2G | 0.80601739 |
| 95 | CAMK2D | 0.79613524 |
| 96 | EPHB2 | 0.79526577 |
| 97 | STK38L | 0.78309691 |
| 98 | PRKCZ | 0.78219392 |
| 99 | EPHA2 | 0.77709439 |
| 100 | DYRK1B | 0.77661658 |
| 101 | MAP3K3 | 0.76836058 |
| 102 | MAPK15 | 0.76771284 |
| 103 | ICK | 0.75914921 |
| 104 | MAP3K4 | 0.75530432 |
| 105 | ILK | 0.73400574 |
| 106 | FGFR2 | 0.72879498 |
| 107 | IRAK3 | 0.71210885 |
| 108 | PRKCI | 0.70924983 |
| 109 | CSK | 0.70407783 |
| 110 | PAK6 | 0.69850317 |
| 111 | ADRBK1 | 0.68653904 |
| 112 | ERBB3 | 0.68351092 |
| 113 | GSK3A | 0.66095636 |
| 114 | MAP3K13 | 0.65620992 |
| 115 | CDK6 | 0.65441814 |
| 116 | MAP3K1 | 0.64997921 |
| 117 | PDK2 | 0.63784077 |
| 118 | CAMK1D | 0.63495271 |
| 119 | BMX | 0.62047780 |
| 120 | PDPK1 | 0.59336811 |
| 121 | PRKAA1 | 0.57136764 |
| 122 | CCNB1 | 0.56666075 |
| 123 | DAPK1 | 0.56631435 |
| 124 | CAMK1 | 0.54623835 |
| 125 | PAK3 | 0.53953504 |
| 126 | MAPK12 | 0.53760678 |
| 127 | CSNK1A1 | 0.52612808 |
| 128 | EPHA3 | 0.52582926 |
| 129 | PRKCQ | 0.51040442 |
| 130 | PRKACA | 0.51028937 |
| 131 | ROCK1 | 0.50967780 |
| 132 | CSF1R | 0.50403340 |
| 133 | RPS6KA5 | 0.50336408 |
| 134 | MYLK | 0.49323328 |
| 135 | UHMK1 | 0.47541887 |
| 136 | DAPK3 | 0.47170840 |
| 137 | TIE1 | 0.46599325 |
| 138 | MAP2K3 | 0.46527830 |
| 139 | CDK8 | 0.45141362 |
| 140 | PIM2 | 0.44808171 |
| 141 | CDK5 | 0.44637426 |
| 142 | RPS6KB2 | 0.44016480 |
| 143 | TGFBR2 | 0.43117455 |
| 144 | AKT3 | 0.41960843 |
| 145 | STK38 | 0.41748255 |
| 146 | NEK6 | 0.41582259 |
| 147 | PRKD3 | 0.40450130 |
| 148 | CSNK1D | 0.40336961 |
| 149 | MAP3K8 | 0.39771965 |
| 150 | PRKCA | 0.38949291 |
| 151 | SGK494 | 0.38796188 |
| 152 | SGK223 | 0.38796188 |
| 153 | EGFR | 0.37477047 |
| 154 | IGF1R | 0.37413968 |
| 155 | PLK3 | 0.36374605 |
| 156 | EPHA4 | 0.36194090 |
| 157 | BCR | 0.35618031 |
| 158 | PRKG1 | 0.35419545 |
| 159 | PDK1 | 0.33611070 |
| 160 | IKBKE | 0.33416006 |
| 161 | MTOR | 0.33320646 |
| 162 | GRK1 | 0.30120823 |
| 163 | RET | 0.29118046 |
| 164 | CAMK4 | 0.28420017 |
| 165 | NME1 | 0.28194223 |
| 166 | PDK3 | 0.25312908 |
| 167 | PDK4 | 0.25312908 |
| 168 | CSNK1G1 | 0.24804964 |
| 169 | NEK1 | 0.24702180 |
| 170 | PRKCG | 0.24227787 |
| 171 | CDK4 | 0.23994943 |
| 172 | SRC | 0.20769461 |
| 173 | MAPK7 | 0.20668733 |
| 174 | FER | 0.20070734 |
| 175 | SGK3 | 0.20038038 |
| 176 | TAOK1 | 0.19358992 |
| 177 | RPS6KA3 | 0.19172177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.11776075 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.59161908 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.47123353 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39902293 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.92132623 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85454325 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82086432 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.77317725 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70637888 |
| 10 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.61620412 |
| 11 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.57727846 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.57476298 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43676869 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40135005 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36610939 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33040736 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.27940028 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22348309 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.17882094 |
| 20 | Protein export_Homo sapiens_hsa03060 | 2.16824475 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13036827 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09260243 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 2.07481902 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 2.06710748 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92804148 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88004687 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84295052 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.84248432 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.77126120 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77077534 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.73217510 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73131658 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.72954936 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72891110 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68523379 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64636135 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64427860 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55628567 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53613419 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52135326 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51677738 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50294804 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50198323 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47906963 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.46484692 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45234982 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.43651789 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43175013 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42373396 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41528041 |
| 51 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.41370859 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36850794 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.35152893 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35046835 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34301067 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32987480 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31965409 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.30447529 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 1.25155701 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21280499 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19869720 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18775827 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17522364 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17300703 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15301754 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15017186 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10414092 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09130801 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07945763 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05943957 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05778698 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 1.05404458 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02621650 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 1.02279249 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01956189 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00001834 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99897936 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97604592 |
| 79 | Ribosome_Homo sapiens_hsa03010 | 0.97041230 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90948190 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90724981 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90176959 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89290471 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88878551 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87272985 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.87238027 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86479596 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82490870 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81998316 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.80966764 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80606211 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79780619 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79670199 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74867875 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73067327 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68510132 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68199297 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66140782 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64921321 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.64428807 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62820108 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61366091 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61017946 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60346755 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58736096 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58381966 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.57746005 |
| 108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56292434 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55685280 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54732748 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51137889 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51000908 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50500457 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50188418 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.50116223 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50077392 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47253356 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46727378 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45210299 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43449403 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42601620 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30183903 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27734844 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.27459379 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.26344427 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18665109 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16273263 |
| 128 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14882972 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.13718947 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13591415 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09379504 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07890772 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01573154 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2800040 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2768743 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | -0.2608818 |
| 137 | Pertussis_Homo sapiens_hsa05133 | -0.2539042 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2052824 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1686733 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | -0.1629244 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | -0.1571395 |
| 142 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1562523 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1547709 |
| 144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1485226 |
| 145 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1385241 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1092967 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1084675 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1046041 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0737943 |
| 150 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0670195 |
| 151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0221207 |

